Search Page

1

Cite

Share

Metal Drugs and the Anticancer Immune Response.

Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Englinger B, et al. Among authors: heffeter p. Chem Rev. 2019 Jan 23;119(2):1519-1624. doi: 10.1021/acs.chemrev.8b00396. Epub 2018 Nov 29. Chem Rev. 2019. PMID: 30489072 Review.

Cite

Share

2

Cite

Share

Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.

Mathuber M, Schueffl H, Dömötör O, Karnthaler C, Enyedy ÉA, Heffeter P, Keppler BK, Kowol CR. Mathuber M, et al. Among authors: heffeter p. Inorg Chem. 2020 Dec 7;59(23):17794-17810. doi: 10.1021/acs.inorgchem.0c03083. Epub 2020 Nov 21. Inorg Chem. 2020. PMID: 33222438 Free PMC article.

Cite

Share

3

Cite

Share

Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib.

Bielec B, Poetsch I, Ahmed E, Heffeter P, Keppler BK, Kowol CR. Bielec B, et al. Among authors: heffeter p. Molecules. 2020 Mar 4;25(5):1149. doi: 10.3390/molecules25051149. Molecules. 2020. PMID: 32143435 Free PMC article.

Cite

Share

4

Cite

Share

EGFR-targeting peptide-coupled platinum(IV) complexes.

Mayr J, Hager S, Koblmüller B, Klose MHM, Holste K, Fischer B, Pelivan K, Berger W, Heffeter P, Kowol CR, Keppler BK. Mayr J, et al. Among authors: heffeter p. J Biol Inorg Chem. 2017 Jun;22(4):591-603. doi: 10.1007/s00775-017-1450-7. Epub 2017 Apr 12. J Biol Inorg Chem. 2017. PMID: 28405842 Free PMC article.

Cite

Share

5

Cite

Share

Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib.

Bielec B, Schueffl H, Terenzi A, Berger W, Heffeter P, Keppler BK, Kowol CR. Bielec B, et al. Among authors: heffeter p. Bioorg Chem. 2020 Jun;99:103778. doi: 10.1016/j.bioorg.2020.103778. Epub 2020 Mar 20. Bioorg Chem. 2020. PMID: 32229347

Cite

Share

6

Cite

Share

A-ring and E-ring modifications of the cytotoxic alkaloid Luotonin A: Synthesis, computational and biological studies.

Ibric A, Battisti V, Deckardt S, Haller AV, Lee C, Prötsch C, Langer T, Heffeter P, Schueffl HH, Marian B, Haider N. Ibric A, et al. Among authors: heffeter p. Bioorg Med Chem. 2020 May 1;28(9):115443. doi: 10.1016/j.bmc.2020.115443. Epub 2020 Mar 16. Bioorg Med Chem. 2020. PMID: 32201190 Free article.

Cite

Share

7

Cite

Share

A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt^IV Complexes under Physiological Conditions.

Kastner A, Poetsch I, Mayr J, Burda JV, Roller A, Heffeter P, Keppler BK, Kowol CR. Kastner A, et al. Among authors: heffeter p. Angew Chem Int Ed Engl. 2019 May 27;58(22):7464-7469. doi: 10.1002/anie.201900682. Epub 2019 Apr 25. Angew Chem Int Ed Engl. 2019. PMID: 30870571 Free PMC article.

Cite

Share

8

Cite

Share

Effects of pharmacological calcimimetics on colorectal cancer cells over-expressing the human calcium-sensing receptor.

Iamartino L, Elajnaf T, Gall K, David J, Manhardt T, Heffeter P, Grusch M, Derdak S, Baumgartner-Parzer S, Schepelmann M, Kallay E. Iamartino L, et al. Among authors: heffeter p. Biochim Biophys Acta Mol Cell Res. 2020 Dec;1867(12):118836. doi: 10.1016/j.bbamcr.2020.118836. Epub 2020 Aug 27. Biochim Biophys Acta Mol Cell Res. 2020. PMID: 32861746 Free article.

Cite

Share

9

Cite

Share

Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development.

Heffeter P, Pape VFS, Enyedy ÉA, Keppler BK, Szakacs G, Kowol CR. Heffeter P, et al. Antioxid Redox Signal. 2019 Mar 10;30(8):1062-1082. doi: 10.1089/ars.2017.7487. Epub 2018 Feb 26. Antioxid Redox Signal. 2019. PMID: 29334758 Review.

Cite

Share

10

Cite

Share

Position-Selective Synthesis and Biological Evaluation of Four Isomeric A-Ring Amino Derivatives of the Alkaloid Luotonin A.

Ibric A, Eckerstorfer S, Eder M, Louko I, Tunjic L, Heffeter P, Schueffl HH, Marian B, Haider N. Ibric A, et al. Among authors: heffeter p. Molecules. 2019 Feb 16;24(4):716. doi: 10.3390/molecules24040716. Molecules. 2019. PMID: 30781470 Free PMC article.

Cite

Share